DK0788496T3 - Inhibitorer for syntese af apolipoprotein-B - Google Patents

Inhibitorer for syntese af apolipoprotein-B

Info

Publication number
DK0788496T3
DK0788496T3 DK95937804T DK95937804T DK0788496T3 DK 0788496 T3 DK0788496 T3 DK 0788496T3 DK 95937804 T DK95937804 T DK 95937804T DK 95937804 T DK95937804 T DK 95937804T DK 0788496 T3 DK0788496 T3 DK 0788496T3
Authority
DK
Denmark
Prior art keywords
apolipoprotein
inhibitors
synthesis
Prior art date
Application number
DK95937804T
Other languages
Danish (da)
English (en)
Inventor
Jan Heeres
Leo Jacobus Jozef Backx
Luc Alfons Leo Van Der Eycken
Robert Jozef Maria Hendrickx
Chaffoy De Courcelles Didie De
Original Assignee
Janssen Pharmaceutica Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US08/455,304 external-priority patent/US5521186A/en
Application filed by Janssen Pharmaceutica Nv filed Critical Janssen Pharmaceutica Nv
Application granted granted Critical
Publication of DK0788496T3 publication Critical patent/DK0788496T3/da

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
    • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
    • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Hematology (AREA)
  • Diabetes (AREA)
  • Obesity (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Steroid Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DK95937804T 1994-10-27 1995-10-19 Inhibitorer for syntese af apolipoprotein-B DK0788496T3 (da)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
EP94203120 1994-10-27
US08/455,304 US5521186A (en) 1994-10-27 1995-05-31 Apolipoprotein-β synthesis inhibitors
PCT/EP1995/004111 WO1996013499A1 (en) 1994-10-27 1995-10-19 Apolipoprotein-b synthesis inhibitors

Publications (1)

Publication Number Publication Date
DK0788496T3 true DK0788496T3 (da) 2001-06-18

Family

ID=26136684

Family Applications (1)

Application Number Title Priority Date Filing Date
DK95937804T DK0788496T3 (da) 1994-10-27 1995-10-19 Inhibitorer for syntese af apolipoprotein-B

Country Status (30)

Country Link
US (1) US5929075A (bg)
EP (1) EP0788496B1 (bg)
JP (1) JP3025907B2 (bg)
KR (1) KR100227231B1 (bg)
CN (1) CN1068000C (bg)
AP (1) AP779A (bg)
AT (1) ATE198889T1 (bg)
AU (1) AU697744C (bg)
BG (1) BG63694B1 (bg)
BR (1) BR9509436A (bg)
CA (1) CA2203274C (bg)
CY (1) CY2256B1 (bg)
CZ (1) CZ286476B6 (bg)
DE (3) DE69519995T2 (bg)
DK (1) DK0788496T3 (bg)
ES (1) ES2155535T3 (bg)
FI (1) FI119548B (bg)
GR (1) GR3035519T3 (bg)
HR (1) HRP950532B1 (bg)
HU (1) HU219862B (bg)
IL (1) IL115771A (bg)
LU (1) LU91306I2 (bg)
NO (1) NO311937B1 (bg)
NZ (1) NZ295353A (bg)
OA (1) OA10479A (bg)
PT (1) PT788496E (bg)
RO (1) RO118715B1 (bg)
SK (1) SK281908B6 (bg)
TR (1) TR199501295A2 (bg)
WO (1) WO1996013499A1 (bg)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EE200000186A (et) * 1997-11-03 2001-04-16 Janssen Pharmaceutica N.V. Osake, selliste osakeste valmistamismeetod ja kasutamine, farmatseutiline doosivorm ja selle valmistamismeetod, tahke dispersioon ja farmatseutiline pakend
CA2328970A1 (en) * 1998-04-27 1999-11-04 Valentin Florent Victor De Conde Pellets having a core coated with a lipid lowering agent and a polymer
EP1140917B1 (en) * 1998-12-22 2003-03-26 Janssen Pharmaceutica N.V. S-oxide lipid lowering compounds
DE19945982A1 (de) 1999-09-24 2001-03-29 Knoll Ag Geschwindigkeitsbestimmte Partikel
US20050132022A1 (en) * 2003-12-12 2005-06-16 International Business Machines Corporation Computer system with LAN-based I/O
CA2552988A1 (en) * 2004-01-21 2005-08-04 Janssen Pharmaceutica Nv Mitratapide oral solution
US7649002B2 (en) 2004-02-04 2010-01-19 Pfizer Inc (3,5-dimethylpiperidin-1yl)(4-phenylpyrrolidin-3-yl)methanone derivatives as MCR4 agonists
US7262318B2 (en) * 2004-03-10 2007-08-28 Pfizer, Inc. Substituted heteroaryl- and phenylsulfamoyl compounds
AU2005230397B2 (en) * 2004-04-09 2010-04-08 Elanco Animal Health Ireland Limited Intermittent dosing regimen for the treatment of overweight with MTP-inhibitors
US20050288340A1 (en) * 2004-06-29 2005-12-29 Pfizer Inc Substituted heteroaryl- and phenylsulfamoyl compounds
PA8660701A1 (es) 2005-02-04 2006-09-22 Pfizer Prod Inc Agonistas de pyy y sus usos
WO2006129193A2 (en) * 2005-05-27 2006-12-07 Pfizer Products Inc. Combination of a cannabinoid-1- receptor-antagonist and a microsomal triglyceride transfer protein inhibitor for treating obesity or mainataining weight loss
JP2009503050A (ja) * 2005-08-04 2009-01-29 ファイザー・リミテッド ピペリジノイル−ピロリジンおよびピペリジノイル−ピペリジン化合物
US7741317B2 (en) 2005-10-21 2010-06-22 Bristol-Myers Squibb Company LXR modulators
US7888376B2 (en) 2005-11-23 2011-02-15 Bristol-Myers Squibb Company Heterocyclic CETP inhibitors
MX2008010899A (es) * 2006-02-23 2008-11-27 Pfizer Ltd Piperidinoilpirrolidinas agonistas del receptor de melanocortina tipo 4.
US8383660B2 (en) 2006-03-10 2013-02-26 Pfizer Inc. Dibenzyl amine compounds and derivatives
KR20090064478A (ko) 2006-11-13 2009-06-18 화이자 프로덕츠 인크. 디아릴, 디피리디닐 및 아릴-피리디닐 유도체, 및 이들의 용도
EP2094643B1 (en) 2006-12-01 2012-02-29 Bristol-Myers Squibb Company N-((3-benzyl)-2,2-(bis-phenyl)-propan-1-amine derivatives as cetp inhibitors for the treatment of atherosclerosis and cardiovascular diseases
CA2685797C (en) * 2007-05-25 2015-04-14 Janssen Pharmaceutica N.V. Improved synthesis of (2s-cis)-2-(bromomethyl)-2-(4-chlorophenyl)-1,3-dioxolane-4-methanol methanesulfonate(ester)
US8592403B2 (en) * 2008-08-06 2013-11-26 Pfizer Limited Diazepine and diazocane compounds as MC4 agonists
BR112012029227B1 (pt) * 2010-05-19 2020-01-07 Sandoz Ag Processo para a preparação de um composto quiral, composto quiral e uso de um composto
LT3762368T (lt) 2018-03-08 2022-06-10 Incyte Corporation Aminopirazindiolio junginiai, kaip pi3k-γ inhibitoriai
WO2020010003A1 (en) 2018-07-02 2020-01-09 Incyte Corporation AMINOPYRAZINE DERIVATIVES AS PI3K-γ INHIBITORS

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218458A (en) * 1978-06-23 1980-08-19 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxy-methyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4313953A (en) * 1978-06-23 1982-02-02 Janssen Pharmaceutica, N.V. Heterocyclic derivatives of (4-aryloxymethyl-1,3-dioxolan-2-yl)methyl-1H-imidazoles and 1H-1,2,4-triazoles
US4766125A (en) * 1981-06-23 1988-08-23 Janssen Pharmaceutica N.V. N-aryl-piperazinealkanamides useful for protecting hearts from myocardial injury caused by ischaemia, anoxia or hypoxia
US4619931A (en) * 1983-02-28 1986-10-28 Janssen Pharmaceutica, N.V. [[4-[4-(4-phenyl-1-piperazinyl)phenoxymethyl]-1,3-dioxolan-2-yl]methyl]-1H-imidazoles and 1H-1,2,4-triazoles
CA1292472C (en) * 1985-12-03 1991-11-26 Alfonsus Guilielmus Knaeps Derivatives of ¬¬4-¬4-(4-phenyl-1-piperazinyl)- phenoxymethyl|-1,3-dioxolan-2-yl|methyl|-1h-imidazoles and 1h-1,2,4-triazoles
NZ223799A (en) * 1987-03-25 1989-12-21 Janssen Pharmaceutica Nv Azolylmethyl-dioxolanylmethoxyphenyl-piperazinyl-phenyl-triazolones and antimicrobial compositions
CA1331757C (en) * 1988-02-29 1994-08-30 Janssen Pharmaceutica Naamloze Vennootschap 5-lipoxygenase inhibiting 4-(4-phenyl-1-piperazinyl)phenols
AU6359594A (en) * 1993-03-04 1994-09-26 Cytoven International N.V. Pharmaceutical tryptophan containing dipeptide compositions and methods of use thereof
US5521186A (en) * 1994-10-27 1996-05-28 Janssen Pharmaceutica N.V. Apolipoprotein-β synthesis inhibitors

Also Published As

Publication number Publication date
CY2256B1 (en) 2003-07-04
GR3035519T3 (en) 2001-06-29
US5929075A (en) 1999-07-27
AU3868095A (en) 1996-05-23
SK50797A3 (en) 1998-04-08
HRP950532B1 (en) 2001-06-30
AP779A (en) 1999-11-03
CA2203274A1 (en) 1996-05-09
OA10479A (en) 2002-04-09
BG63694B1 (bg) 2002-09-30
CZ119897A3 (cs) 1998-03-18
CZ286476B6 (en) 2000-04-12
CN1068000C (zh) 2001-07-04
RO118715B1 (ro) 2003-09-30
EP0788496B1 (en) 2001-01-24
KR100227231B1 (ko) 1999-11-01
CA2203274C (en) 2002-02-19
NZ295353A (en) 1998-08-26
MX9703074A (es) 1997-07-31
FI971784A (fi) 1997-04-25
NO971895L (no) 1997-04-24
PT788496E (pt) 2001-07-31
SK281908B6 (sk) 2001-09-11
BG101402A (bg) 1997-10-31
DE122007000005I1 (de) 2007-04-26
DE69519995D1 (en) 2001-03-01
FI119548B (fi) 2008-12-31
BR9509436A (pt) 1998-01-06
IL115771A (en) 2000-02-29
ATE198889T1 (de) 2001-02-15
LU91306I2 (fr) 2007-03-19
HRP950532A2 (en) 1997-08-31
HUT77360A (hu) 1998-03-30
IL115771A0 (en) 1996-01-19
AP9700968A0 (en) 1997-04-30
DE122007000005I2 (de) 2008-04-24
EP0788496A1 (en) 1997-08-13
AU697744C (en) 2002-08-22
CN1161695A (zh) 1997-10-08
AU697744B2 (en) 1998-10-15
TR199501295A2 (tr) 1996-06-21
ES2155535T3 (es) 2001-05-16
NO971895D0 (no) 1997-04-24
JP3025907B2 (ja) 2000-03-27
FI971784A0 (fi) 1997-04-25
WO1996013499A1 (en) 1996-05-09
NO311937B1 (no) 2002-02-18
HU219862B (hu) 2001-08-28
JPH09511759A (ja) 1997-11-25
DE69519995T2 (de) 2001-08-23

Similar Documents

Publication Publication Date Title
DK0788496T3 (da) Inhibitorer for syntese af apolipoprotein-B
DK0773940T3 (da) Fremgangsmåde til syntese af substituerede sulfoxider
DK1445259T3 (da) Anvendelse af krystalformer for 2-methyl-thieno-benzodiazepin
LV11178A (lv) 3-Ú4-(2-aminoetoksi) benzoil¾-2-aril-6-hidroksibenzoÚb¾tiofenu sintezes panemiens
FI963597A0 (fi) Isoprenyylitransferaasi-inhibiittoreita
NO972930D0 (no) Fibronectin-adhesjonsinhibitorer
BR9612465A (pt) Compostos heterocíclicos
FI972160A (fi) Matriisimetalloproteaasi-inhibiittorit
ID24638A (id) Senyawa-senyawa anti aritmia bispidina
DK0820451T3 (da) Hidtil ukendte heterocykliske forbindelser
EE04241B1 (et) Apolipoproteiin-B sünteesi inhibiitorid
NO963187D0 (no) Fremgangsmåte for syntese av gamma-pyroner
IT1295934B1 (it) Procedimento migliorato per la sintesi di alchilpoliglucosidi
DK1023292T3 (da) Fremgangsmåde til syntese af chlorpurinintermediater
BR9708718A (pt) Sínteses de aminas substituídas
DK0857720T3 (da) Fremgangsmåde til syntese af desoxypyridinolin
ITMI941144A0 (it) Procedimento per la formazione di timbri
CY2007006I1 (el) Αναστολεις συνθεσης απολιποπρωτεινης-β
KR970001314A (ko) 신규한 포름아미딘 화합물
KR960015946U (ko) 레이져 트리머의 양면 부품용 척
DK0851865T3 (da) Hidtil ukendte heterocykliske forbindelser
KR960005897U (ko) 측량용자 고정대
UA852S (uk) Набір ваз
ITRC940003A0 (it) Campanello per appuntamenti
SE9402122D0 (sv) Heterocyclic compounds